CarMax: No Competitive Advantages And Still Too Expensive
Seeking Alpha· 2025-12-19 13:00
Core Insights - The article emphasizes the importance of identifying high-quality companies with a strong track record of reinvesting capital for significant returns, aiming for a long-term capital compounding capability that could yield tenfold returns or more [1]. Investment Strategy - The investment approach is primarily conservative, focusing on long-term holdings to achieve higher returns compared to market indices, especially in a landscape where short-term investments are becoming more common [1]. - Occasionally, the strategy may include pursuing opportunities with a favorable risk-reward ratio, where the potential upside is substantial and the downside is limited, ensuring overall portfolio stability [1].
Novo Nordisk: Oral Wegovy, Supply Chain, And Restructuring = Big Upside Ahead
Seeking Alpha· 2025-12-19 13:00
Core Insights - The article emphasizes the importance of identifying high-quality dividend-growing and undervalued investment opportunities to achieve strong total returns through cash dividends and capital gains [1] Company Analysis - Scott Kaufman, known as Treading Softly, has over a decade of experience in the financial sector, focusing on actionable insights for dividend investments [1] - The lead analyst for Dividend Kings aims to provide a robust total return by focusing on both cash dividends and capital gains [1]
NXP: Too Much Uncertainty To Recommend (NYSE:NXC)
Seeking Alpha· 2025-12-19 13:00
With a focus on REITs, ETFs, Preferreds, and 'Dividend Champions' across asset classes, members gain complete access to our research and our suite of trackers and portfolios targeting premium dividend yields up to 10%.iREIT®+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income, diversification, and inflation hedging. Get started with a Free Two-Week Trial and take a look at ou ...
Aduro Clean Technologies Announces Pricing of US$20 Million Underwritten Public Offering
Globenewswire· 2025-12-19 13:00
LONDON, Ontario, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the pricing of its underwritten U.S. public offering (the “Offering”) of 1,739,130 common shares, together with accompanying warrants to purchase 869,565 common sha ...
Esperion’s Bempedoic Acid Receives Recommendation in 2025 ACC Scientific Statement on Management of Peripheral Artery Disease in Adults With Diabetes
Globenewswire· 2025-12-19 13:00
– Bempedoic Acid Highlighted by ACC for LDL-C Lowering in Patients with Peripheral Artery Disease and Diabetes Based on Proven Cardiovascular and Limb Benefits – ANN ARBOR, Mich., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) welcomed the inclusion of bempedoic acid as a first-line, evidence-based therapy for LDL-C lowering for patients on maximally tolerated statins in the 2025 American College of Cardiology (ACC) Scientific Statement on Management of Peripheral Artery Disease (PAD) in Adults w ...
AiRWA Inc. Announces $15.69 Million Common Stock Registered Direct Priced At Market Close
Globenewswire· 2025-12-19 13:00
Smyrna, Delaware, Dec. 19, 2025 (GLOBE NEWSWIRE) -- AiRWA Inc. (Nasdaq: YYAI) (the “Company”), a technology licensing company developing a next-generation RWA-focused exchange for the trading of tokenized U.S. equities, today announced that it has entered into securities purchase agreements with investors for the purchase and sale of 15,382,378 shares of common stock at a purchase price of $1.02 per share, pursuant to a registered direct offering, resulting in gross proceeds of approximately $15.69 million, ...
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
Globenewswire· 2025-12-19 13:00
$20.1 million upfront with a milestone-driven additional $20.1 million to advance INB-619, IN8bio’s novel gamma-delta (“γδ”) T cell engager through an Investigational New Drug (“IND”) application Financing led by Coastlands Capital with participation from new and existing biotechnology investors Initial proceeds extend cash runway into the first half of 2027 NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (“IN8Bio” or the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company develo ...
DraftKings Debuts Predictions App, Entering Prediction Markets
Globenewswire· 2025-12-19 13:00
New standalone mobile app applies DraftKings’ proven technology to event contracts, offering a streamlined experience and expanding the Company’s product portfolioBOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- DraftKings Inc. (NASDAQ: DKNG) (“DraftKings” or the “Company”) today announced the launch of DraftKings Predictions, formally entering prediction markets under the oversight of the U.S. Commodity Futures Trading Commission (CFTC). DraftKings Predictions is a new standalone mobile app and web product that a ...
Foremost Clean Energy Announces Results from AGM
Globenewswire· 2025-12-19 13:00
VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”), is pleased to announce the voting results from its annual general meeting of shareholders (the “Meeting”) held on December 16, 2025. All matters submitted to shareholders for approval at the Meeting were approved in accordance with management’s recommendations, including: (a) fixing the number of directors of the Company at six (6) and electing the following ind ...
2026 Market Outlook: 6 Growth Drivers, S&P 500 +14%
Seeking Alpha· 2025-12-19 13:00
David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability Company. As an investor entrepreneur, David invests in stocks, bonds, options, ETFs, REITs, real estate, closed end funds and alternative investment funds such as hedge funds and private credit. With over 30 years’ experience in investing, David holds a Master of Science (MS) Degree in Finance, with a concentration in Investment Analysis, from Boston University, a Certificate in Financial Planning, and ...